AntibioticsORALGeneric
V-CILLIN
PENICILLIN V
Standard Dose
125MG/0.6ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview V-CILLIN is listed in Drugs@FDA under application 060002 (ANDA).
Marketing status: Discontinued Active ingredient PENICILLIN V Form and strength FOR SUSPENSION;ORAL - 125MG/0.6ML Sponsor LILLY Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview V-CILLIN is listed in Drugs@FDA under application 060002 (ANDA). Marketing status: Discontinued Active ingredient PENICILLIN V Form and strength FOR SUSPENSION;ORAL - 125MG/0.6ML Sponsor LILLY Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.